Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. (Q39457063)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 1999

Language	Label	Description	Also known as
English	Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.	scientific article published on February 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930869%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930869%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

0 references

1 reference

based on heuristic

inferred from title

0 references

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930869%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

Shibata R

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930869%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Igarashi T

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930869%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Buckler-White A

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930869%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Ogert R

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930869%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Ross W

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930869%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Willey R

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930869%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Cho MW

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930869%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Martin MA

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930869%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

0 references

publication date

1 February 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930869%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Nature Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930869%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930869%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930869%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

204-210

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930869%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1038%2F5568

21 January 2018

Macaque models for AIDS vaccine development

1 reference

https://api.crossref.org/works/10.1038%2F5568

21 January 2018

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

1 reference

https://api.crossref.org/works/10.1038%2F5568

21 January 2018

HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees

1 reference

https://api.crossref.org/works/10.1038%2F5568

21 January 2018

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2F5568

21 January 2018

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1038%2F5568

21 January 2018

Prevention of HIV infection by passive immunization with HIV immunoglobulin

1 reference

https://api.crossref.org/works/10.1038%2F5568

21 January 2018

Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: determinants of high virus loads and CD4 cell killing

1 reference

https://api.crossref.org/works/10.1038%2F5568

21 January 2018

Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.

1 reference

https://api.crossref.org/works/10.1038%2F5568

21 January 2018

HIV type 1 coreceptors, neutralization serotypes, and vaccine development

1 reference

https://api.crossref.org/works/10.1038%2F5568

21 January 2018

Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing

1 reference

https://api.crossref.org/works/10.1038%2F5568

21 January 2018

Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile

1 reference

https://api.crossref.org/works/10.1038%2F5568

21 January 2018

Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2F5568

7 January 2021

based on heuristic

inferred from DOI database lookup

Infectious hepatitis. Studies on the effect of gamma globulin and on the incidence of inapparent infection

1 reference

https://api.crossref.org/works/10.1038%2F5568

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2F5568

7 January 2021

based on heuristic

inferred from DOI database lookup

Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus.

1 reference

https://api.crossref.org/works/10.1038%2F5568

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactivation of HIV type 1 in chronically infected chimpanzees following xenostimulation with human cells or with pulses of corticosteroid

1 reference

https://api.crossref.org/works/10.1038%2F5568

7 January 2021

based on heuristic

inferred from DOI database lookup

Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120

1 reference

https://api.crossref.org/works/10.1038%2F5568

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T-lymphocyte and macrophage cultures

1 reference

https://api.crossref.org/works/10.1038%2F5568

7 January 2021

based on heuristic

inferred from DOI database lookup

Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2F5568

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4

1 reference

https://api.crossref.org/works/10.1038%2F5568

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930869%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9930869%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39457063&oldid=2202898680"